Skip to search formSkip to main contentSkip to account menu

traxanox

Known as: 5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt, 9-chloro-5-oxo-7-(1H-tetrazol-5-yl)-5H-(1)benzopyrano(2,3-b)pyridine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Many anti-allergic drugs for the treatment of allergic rhinitis are manufactured or available for sale in Japan. These include… 
1988
1988
Traxanox sodium was given in a dose of 360 mg/day to 19 patients with nasal allergy. Improvement was “moderate” or better in 65… 
1984
1984
The production of spleen- and thymus-rosette forming cells (RFC) in BALB/c mice 4 days after immunization with 5 X 10(8) sheep… 
1983
1983
The effect of traxanox on SRS-A release was examined in vivo and compared with that of disodium cromoglycate (DSCG). Intravenous… 
1983
1983
Both C57BL/6 and BALB/c mice were immunized intravenously with lipopolysaccharide (LPS, 10 micrograms/mouse) on day 0, and… 
1983
1983
Traxanox at the upper dose of 300 mg/kg, p.o., showed no effect on the somatic and autonomic nervous systems in the various tests… 
1983
1983
The effects of traxanox, an anti-allergic drug, on the cardiovascular system were studied in both anesthetized dogs and cats and… 
1983
1983
Traxanox sodium salt pentahydrate (9-chloro-5-oxo-7-(1H-tetrazol-5-yl)-5H-[1] benzopyrano [2, 3-b] pyridine sodium salt… 
1982
1982
Traxanox sodium, a benzopyranopyridine derivative showing a potent oral antiallergic activity in the rat, was compared with… 
1982
1982
The 48-hour passive cutaneous anaphylaxis (PCA) and passive anaphylactic bronchoconstriction in rats induced by an IgE-like…